|
Extended indication |
Nintedanib Accord is a medicine used to treat adults with idiopathic pulmonary fibrosis (IPF), a disease of unknown cause in which fibrous tissue forms in the lungs;
systemic sclerosis associated interstitial lung disease, a disease in which the immune system (the body’s natural defences) is overactive, causing production of fibrous tissue and progressive scarring of the lungs;
other chronic fibrosing interstitial lung diseases which are progressive.
|